5th International Hospital Diabetes Meeting AGENDA Friday, May 8, 2015 08:00
Welcome David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE Mills-Peninsula Health Services, San Mateo, California
08:02
Opening Remarks Guillermo Umpierrez, MD Emory University, Atlanta, Georgia
Keynote Address 08:05
Reliability in Health Care Erin S. DuPree, MD, FACOG Joint Commission Center for Transforming Healthcare Oakbrook Terrace, Illinois
Session 1: Measuring Glucose in Hospitalized and Critically Ill Patients 08:35
GlucometricsÑMetrics That Matter and Drive Improvement Greg Maynard, MD, MSc, SFHM UC Davis, Sacramento, California
08:55
Glucose Variability in the Hospital Setting Gerry Rayman, MD, FRCP Ipswich Hospital Diabetes Center, Ipswich, United Kingdom
09:15
POC Blood Glucose Impact of FDA Guidelines MayMonitoring 8–9, 2015and • San Francisco, California for Critically Ill Patients Mitchell G. Scott, PhD, DABCC Washington University, St. Louis, Missouri
09:45
Impact of CMS Guidelines on POC BGM in Critically Ill Patients David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE Mills-Peninsula Health Services, San Mateo, California
09:55
Group Discussion
10:15
Break
Friday, May 8, 2015 AGENDA, continued Session 2: Glycemic Targets in Various Settings 10:40
ICU Stanley A. Nasraway, MD Tufts Medical Center, Boston, Massachusetts
11:00
Non-ICU Garry S. Tobin, MD Washington University, St. Louis, Missouri
11:20
Pediatric ICU Darrell M. Wilson, MD Stanford University, Stanford, California
11:40
Transitions in Diabetes Care: Inpatient to Outpatient Amisha Wallia, MD, MS Northwestern Medical Group, Chicago, Illinois
12:00
Group Discussion
12:20
Lunch (located at Poolside Pavilion) Lunch Program: Avoiding Bloodborne Virus Disease Transmission from Assisted Monitoring of Blood Glucose in the Hospital A Pathologist‘s Perspective Sharon Geaghan, MD Stanford University, Stanford, California A Patient’s Perspective Christel Marchand Aprigliano, BA, MSc StripSafely, Tampa, Florida
13:20
Break
Friday, May 8, 2015 AGENDA, continued Session 3: Technology 13:50
BGM in the Hospital: State of the Art Mitchell G. Scott, PhD, DABCC Washington University, St. Louis, Missouri
14:10
Continuous Glucose Monitoring in the Hospital Stanley A. Nasraway, MD Tufts Medical Center, Boston, Massachusetts
14:30
Computerized Insulin Infusion Programs (Glucommander and Others) Guillermo Umpierrez, MD Emory University, Atlanta, Georgia
14:50
Regulation of Glucose Monitoring and Insulin Dosing Software for Hospitalized Patients Alberto Gutierrez, PhD U.S. Food and Drug Administration, Silver Spring, Maryland
15:10
Group Discussion
15:30
Break
.
Session 4: Glucose Management Teams 15:55
The Role of the Certified Diabetes Educator (CDE) on Glycemic Control Teams Jane Jeffrie Seley, DNP, MPH, BC-ADM, CDE, CDTC New York-Presbyterian/Weill Cornell, New York, New York
16:15
Collaborative Model to Enhance Surgical Diabetes Patient Care Curtiss B. Cook, MD Mayo Clinic, Scottsdale, Arizona
16:35
The Virtual Inpatient Glucose Management Service Robert J. Rushakoff, MD UC San Francisco, San Francisco, California
16:55
Group Discussion
17:10
Adjourn
AGENDA Saturday, May 9, 2015 08:00
Introduction David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE Mills-Peninsula Health Services, San Mateo, California
Session 5: Insulin Dosing and Safety 08:05
Using Algorithms to Improve Insulin Dosing and Safety Greg Maynard, MD, MSc, SFHM UC Davis, Sacramento, California
08:25
Decision Support Software Thomas Pieber, MD Medical University of Graz, Graz, Austria
08:45
Creating User-Friendly Insulin Order Sets: Balancing Safety and Efficacy Jane Jeffrie Seley, DNP, MPH, BC-ADM, CDE, CDTC New York-Presbyterian/Weill Cornell, New York, New York
09:05
Pump Safety in the Hospital in Various Settings including the OR and Radiology Robert J. Rushakoff, MD UC San Francisco, San Francisco, California
09:25
Group Discussion
09:50
Break
Session 6: Hypoglycemia 10:15
Mechanisms/Symptoms/Frequency Thomas Pieber, MD Medical University of Graz, Graz, Austria
10:35
Prevention Garry S. Tobin, MD Washington University, St. Louis, Missouri
Saturday, May 9, 2015 AGENDA, continued 10:55
Hypoglycemia and Adverse Cardiovascular Events: Marker or Mediator? Mikhail Kosiborod, MD Saint Luke’s Mid America Heart Institute Kansas City, Missouri
11:15
The Economic Burden of Hypoglycemia Robert A. Vigersky, MD Medical Director, Medical Affairs, Medtronic Diabetes Professor of Medicine Uniformed Services University of the Health Sciences Director Emeritus Diabetes Institute Walter Reed National Military Medical Center
11:35
Group Discussion
12:00
Lunch (located at Cascades)
Session 7: Special Populations 13:00
Steroids, Tube Feeding, and TPN Boris Draznin, MD, PhD University of Colorado, Aurora, Colorado
13:20
Special Situations: Surgery Mark J. Rice, MD Vanderbilt University, Nashville, Tennessee
13:40
Transplant Management Amisha Wallia, MD, MS Northwestern Medical Group, Chicago, Illinois
14:00
Foot Disease in the Hospital Gerry Rayman, MD, FRCP Ipswich Hospital Diabetes Center, Ipswich, United Kingdom
14:20
Group Discussion
14:45
Break
Saturday, May 9, 2015 AGENDA, continued Session 8: Novel Therapeutics 15:10
New Insulins Robert A. Vigersky, MD Medical Director, Medical Affairs, Medtronic Diabetes Professor of Medicine Uniformed Services University of the Health Sciences Director Emeritus Diabetes Institute Walter Reed National Military Medical Center
15:35
Insulin Pump Therapy in the Perioperative Period: Update on a Quality Initiative Curtiss B. Cook, MD Mayo Clinic, Scottsdale, Arizona
16:00
SGLT-2 Inhibitors: Potential Role in Patients with CVD Mikhail Kosiborod, MD Saint Luke’s Mid America Heart Institute Kansas City, Missouri
16:25
Group Discussion
16:50
Closing Remarks Robert A. Vigersky, MD Medical Director, Medical Affairs, Medtronic Diabetes Professor of Medicine Uniformed Services University of the Health Sciences Director Emeritus Diabetes Institute Walter Reed National Military Medical Center
17:00
Adjourn